
Increasing global travel and rapid viral evolution continues to fuel annual flu epidemics. While widespread public health vaccination campaigns help prevent some infections, the efficacy of the vaccine varies – depending on the dominant strains each year.
An estimated 45 million Americans were infected by the influenza virus in the 2017-2018 season resulting in over 800,000 hospitalizations and 61,000 deaths. In 2020 28.2 million Americans contracted SARS-CoV-2, resulting in 500,000 deaths. Worldwide, 112 million have tested COVID positive, and over 2.4 million have died.
The Seraph Research team is developing new treatments to reduce the severity and length of infection and help prevent the high number of deaths each year.
Fighting against HIV/AIDS through the pursuit of innovative and revolutionary prevention and treatment strategies — with the goal of creating a cure.
Groundbreaking research and development, designed to prevent and eradicate the coronavirus and all SARS related virus mutations.
Spearheading medical scientific research efforts using novel and proprietary mechanism of action, that directly targets the virus at its source.
Developing new treatments to reduce the severity and length of infection, and help prevent the high number of influenza related deaths each year.
For research updates and news, please enter your email address in the field below.
©2020 | Seraph Research Institute
Individualized Research Team Give